Top compounds associated with response to INTS4


Feature Type Standardized
Nominal ANOVA
mRNA sitagliptin CTRPv2 pan-cancer AAC -0.063 0.4
mRNA rigosertib CTRPv2 pan-cancer AAC 0.027 0.4
mRNA ML210 CTRPv2 pan-cancer AAC -0.027 0.4
mRNA SRT-1720 CTRPv2 pan-cancer AAC 0.03 0.4
mRNA serdemetan:SCH-529074 (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.029 0.4
mRNA tanespimycin:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.027 0.4
mRNA canertinib CTRPv2 pan-cancer AAC 0.029 0.4
mRNA IC-87114 CTRPv2 pan-cancer AAC -0.03 0.4
mRNA Gefitinib CTRPv2 pan-cancer AAC 0.029 0.4
mRNA GSK269962A GDSC1000 pan-cancer AAC -0.027 0.4
Download CSV